How biopharma companies are bolstering R&D pipeline through deal-making
Sourcing research externally seems to be the preferred path for biopharma companies to strengthen their R&D pipeline. But when choosing from the three main options open to them—licensing, mergers and acquisitions, and joint ventures—what factors should they examine, and do deal types differ in the ways they accelerate development and deliver long-term value?
Health Care Blog
A View from the Center
Read the Center for Health Solutions blog, sharing timely insights, research, and forward thinking for the life sciences and health care industry.
Health Care Current library
Weekly insights in the US health care industry
This weekly series explores breaking news and developments in the US health care industry; examines key issues facing life sciences and health care companies; and provides updates and insights on policy, regulatory, and legislative changes.